The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 410.00
Bid: 386.00
Ask: 410.00
Change: 20.00 (5.13%)
Spread: 24.00 (6.218%)
Open: 410.00
High: 410.00
Low: 410.00
Prev. Close: 390.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

9 Jul 2020 07:00

RNS Number : 4414S
Zotefoams PLC
09 July 2020
 

9 July 2020

Zotefoams plc

(''Zotefoams')

 

Notice of Results

 

Zotefoams, a world leader in cellular materials technology, will announce its interim results for the six months to 30 June 2020 on 11 August 2020.

An analyst meeting will take place at 9.30am on the day. Analysts interested in attending the presentation should please contact IFC Advisory: zach.cohen@investor-focus.co.uk

In addition, David Stirling, Group CEO, and Gary McGrath, Group CFO, will be hosting an interactive presentation on Investor Meet Company at 5.30pm on 11 August 2020:

https://investormeetcompany.com/zotefoams-plc/register-investor

·

The online presentation is open to all existing and potential shareholders.

·

Questions can be submitted pre-event via your IMC dashboard or any time during the live presentation via the "Ask a Question" function. Although Zotefoams may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.

·

Investor feedback can also be submitted directly to management post-event to ensure Zotefoams can understand the views of all elements of its shareholder base.

 

Enquiries:

Zotefoams plc 44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

IFC Advisory (Financial PR & IR) 44 (0) 203 934 6630

Graham Herring

Zach Cohen

 

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORRPMITMTTMBFM
Date   Source Headline
7th Aug 20187:00 amRNSInterim Results
25th Jul 20182:47 pmRNSHolding(s) in Company
25th Jul 20182:47 pmRNSHolding(s) in Company
16th Jul 20189:12 amRNSHolding(s) in Company
12th Jul 201811:47 amRNSDirector/PDMR Shareholding
9th Jul 20187:00 amRNSNotice of Results
12th Jun 20184:45 pmRNSDirector/PDMR Shareholding
4th Jun 20185:50 pmRNSDirector/PDMR Shareholding
4th Jun 20189:30 amRNSDirector Declaration
1st Jun 20184:39 pmRNSTotal Voting Rights
1st Jun 20184:37 pmRNSHolding(s) in Company
31st May 201811:57 amRNSDirector/PDMR Shareholding
29th May 20185:34 pmRNSDirector/PDMR Shareholding
22nd May 201812:28 pmRNSHolding(s) in Company
21st May 20184:04 pmRNSHolding(s) in Company
21st May 20187:00 amRNSDirector/PDMR Shareholding
17th May 20184:08 pmRNSHolding(s) in Company
16th May 20181:35 pmRNSResult of AGM
16th May 20187:00 amRNSCompletion of placing
15th May 20184:39 pmRNSProposed placing of shares in Zotefoams plc
14th May 20183:09 pmRNSDirector/PDMR Shareholding
13th Apr 20189:43 amRNSDirector/PDMR Shareholding
12th Apr 20182:27 pmRNS2017 Annual Report and Notice of the 2018 AGM
13th Mar 20185:30 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSFinal Results
9th Mar 20187:00 amRNSHolding(s) in Company
22nd Feb 20184:54 pmRNSHolding(s) in Company
22nd Feb 20184:48 pmRNSHolding(s) in Company
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20184:55 pmRNSHolding(s) in Company
12th Jan 201811:37 amRNSDirector/PDMR Shareholding
22nd Dec 201712:27 pmRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSDirectorate Change
18th Dec 20174:10 pmRNSHolding(s) in Company
14th Dec 20177:00 amRNS£12 million investment planned at Croydon facility
13th Dec 20177:00 amRNSDirector/PDMR Shareholding
13th Dec 20177:00 amRNSStrategic Partnership with Nike
15th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSThird Quarter Trading Update
17th Oct 20171:08 pmRNSDirector/PDMR Shareholding
10th Oct 20177:00 amRNSDirector/PDMR Shareholding
28th Sep 20177:00 amRNSHolding(s) in Company
13th Sep 20177:00 amRNSDirector/PDMR Shareholding
16th Aug 20177:00 amRNSHolding(s) in Company
11th Aug 20175:23 pmRNSHolding(s) in Company
10th Aug 20177:00 amRNSDirector/PDMR Shareholding
8th Aug 20177:00 amRNSDirectorate Changes
8th Aug 20177:00 amRNSHalf-year Report
20th Jul 20177:00 amRNSHolding(s) in Company
12th Jul 201710:19 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.